Month: December 2020

Categories
Politics

Senate seems to be to go funding invoice

Senate looks to pass funding bill

Update: The Senate passed the government’s one-week funding law on Friday afternoon. An earlier version of this story is below.

The Senate had only hours to prevent the government from closing on Friday as lawmakers threatened to halt the swift passage of a spending bill.

Funding goes off if the Chamber does not approve a mediocre measure and President Donald Trump does not sign it before midnight. The House has already approved a week-long extension of government spending until December 18.

Legislators hope the bill will give them more time to finalize elusive year-round funding and coronavirus relief deals. However, it got more complicated to turn the lights on for another week on Friday.

In order to survive the shutdown, the measure requires unanimous approval. This means any senator can delay their approval, and several lawmakers have suggested doing so.

Sens. Bernie Sanders, I-Vt., And Josh Hawley, R-Mo., Urged a vote on a proposal to send direct payments of up to $ 1,200 per person and $ 500 per child. They criticized Congress ‘failure to put more money into Americans’ pockets for months during health and economic crises.

“In the midst of so much economic despair, Congress cannot pause without providing this $ 1,200 emergency aid to the American people in their distress,” Sanders said in a statement Thursday evening as he introduced the amendment he and Hawley proposed to the Senate hope is attached to the financing measure.

Meanwhile, NBC News reported that Florida Republican Sens. Rick Scott and Indiana Mike Braun want to tie a bill to end government closings to the week-long funding.

It is now unclear whether any of the lawmakers will actually delay the passage of the spending bill and let the funding forfeit.

The Senate cleared a potential hurdle when Senator Rand Paul, R-Ky., Told reporters he was not going to hold up the household bill. He delayed the passage of the annual National Defense Approval Act for a day amid concerns about the $ 740 billion cost and a provision that would restrict the president’s authority to withdraw troops from overseas.

A previous protest from Paul resulted in a brief shutdown in 2018.

The passage of the spending measure would keep the government going for just a week. The appropriators have failed to reach a final agreement on a plan to fund the government by September 30, 2021, but Congress leaders said they hope they can do so before next week.

Previously, Republicans and Democrats had agreed on a total price of 1.4 trillion US dollars for a year-round spending package.

Subscribe to CNBC on YouTube.

Categories
World News

Dow futures rise as shares try to bounce again from shedding week

Dow futures rise as stocks attempt to bounce back from losing week

Traders work on the trading floor of the New York Stock Exchange.

NYSE

US stock futures rose early Monday as markets indicated a rebound from a lost week.

Investors are weighing updates on the introduction of the Covid-19 vaccine and the coronavirus stimulus stalemate in Washington

Dow futures indicated an opening gain of more than 180 points. S&P 500 futures and Nasdaq 100 futures also traded in positive territory.

Last week, stocks saw their first week of downturn in several months as lawmakers continued a stalemate over a Covid-19 bailout package.

The S&P 500 fell nearly 1% in its first negative week in three years. The Dow Jones Industrial Average lost 0.57% for its first negative week in three and the Nasdaq Composite lost nearly 0.7% for its first negative week in four.

Next week is expected to be market-moving with the launch of the Pfizer vaccine and a Federal Reserve policy meeting. Tesla is also joining the S&P 500 on Friday.

Following the Food and Drug Administration’s emergency approval for Pfizer’s vaccine, Center for Disease Control and Prevention Director Robert Redfield signed the drug so that vaccinations could officially continue for those aged 16 and over.

The US has started shipping the cans from a Pfizer facility in Michigan to hundreds of distribution centers around the country. The FDA is expected to publish its assessment of Moderna’s vaccine this week.

The Covid-19 vaccine launches on some of the darkest days of the pandemic in the United States. More than 2,300 coronavirus-related deaths were recorded on Saturday, after over 3,300 deaths on Friday. New infections keep exploding. More than 219,000 cases were reported on Saturday.

The surge in cases coincides with months of debates in Washington over another round of Covid relief. A non-partisan group has proposed a $ 908 billion limit. Sen. Majority Leader Mitch McConnell has opposed the proposal, instead calling for an agreement that eliminates corporate liability and funding provisions from state and local governments. These two issues are major sources of disagreement between Republicans and Democrats.

“Politically, the debate continues on more tax legislation that is badly needed for much of the population, but will also create an even bigger ‘wall of money’ for consumers when the economies are fully reopened,” said Raymond James’ Tavis McCourt towards customers on Sunday.

“It is very clear that the economy is slowing as the local stalemate persists, but the impact on the stock market has so far been limited. Whether this will continue through Q1 is unclear, but we expect withdrawals to be limited unless the vaccine changes significantly. ” History, “he added.

The Fed begins its two-day meeting on Tuesday, the last central bank meeting in 2020. Economists have speculated that the Fed might make changes to its bond program. The Fed is currently buying at least $ 80 billion a month from Treasuries, and Fed officials at their last meeting discussed what they could do to change that program.

Subscribe to CNBC PRO for exclusive insights and analysis as well as live business day programs from around the world.

Categories
Business

Aid Therapeutics shares have soared 38,000% in 2020

Relief Therapeutics shares have soared 38,000% in 2020

Medical staff examine a patient in the Covid-19 intensive care unit at the United Memorial Medical Center in Houston on November 16, 2020.

Go Nakamura | Getty Images

LONDON – Swiss biotech company Relief Therapeutics saw its share price jump 38,000% this year as it develops a drug that focuses on respiratory failure due to severe Covid-19.

Last week, the company, together with US partner NeuroRx, achieved the target agreed with the US Food and Drug Administration of 165 patients in the ongoing Phase 2b / 3 study with RLF-100, a patented version of Aviptadil.

Aviptadil is a synthetic formulation of a naturally occurring peptide called Vasoactive Intestinal Polypeptide (VIP), which is primarily concentrated in the lungs and resets the immune system’s response, acts as a vasodilator, and promotes the production of surfactant in the lungs allowing the transfer of blood oxygen.

RLF-100 has been around since 2000, when it was developed to treat acute respiratory distress and other lung diseases and was subsequently acquired by Biogen. Earlier this year, Relief scientists discovered that it could protect the cell attacked by the Covid-19 virus.

Ram Selvaraju, chairman of Relief Therapeutics, spoke to CNBC from New York by phone that the ongoing study is expected to provide topline data in the first half of January, and attributed the company’s stock price surge in part to evidence of effectiveness in ” otherwise untreatable patients. “

“Where other people have mainly focused on lightly infected or moderately infected people, we have tried carefully to see if our drug can benefit the seriously ill and the terminally ill,” he said.

Early results of extended access use of RLF-100 in patients with critical Covid-19 and severe comorbidities showed that 72% of patients admitted to the ICU survived.

Relief Therapeutics had a market cap of less than 100 million Swiss Francs ($ 113 million) in late July and surpassed the first 21 patients treated with RLF-100 under the FDA Expanded Access Protocol on August 10 after promising results 1.6 billion Swiss people. Since then, it has flattened to just under CHF 1 billion.

The 38,000% increase largely corresponds to the low level of the original share price, which was just under 0.40 Swiss francs per share on Friday afternoon. Shares in the multinational Roche, on the other hand, are worth 306 francs.

Other therapeutics that have been tested on patients with more moderate symptoms have been purchased by government agencies to help fight the pandemic. The US government’s Operation Warp Speed ​​ordered Gileads Remdesivir and Eli Lillys Bamlanivimab.

Selvaraju announced that Relief Therapeutics and NeuroRx were in contact with Operation Warp Speed, and said that if the drug successfully proves its effectiveness in critically ill patients after phase three randomized tests, the company expects to see stock orders on a scale similar to that Gilead and Eli Lilly. A US Department of Health spokesman was not immediately available for comment when contacted CNBC.

Covid the “tip of the iceberg”

In June, the FDA granted RLF-100 fast-track designation and also received orphan drug designation for the treatment of acute respiratory distress syndrome (ARDS).

Since the drug is not an antiviral drug specifically designed to fight the coronavirus, Relief Therapeutics hopes the current pandemic is “a chance for this drug to shine” if it turns out to be a therapeutic one clinical benefit in the treatment of respiratory disease due to Covid- hat. 19th

“Covid-19 is really the tip of the iceberg, the head of the spear. If we can prove this drug works for Covid-19-related respiratory distress, we will assume that we can use these results to further develop the drug testing.” in other forms of acute respiratory distress syndrome unrelated to Covid-19, “Selvaraju said, adding that this puts Relief Therapeutics in a” pretty unique position “.

“While many other experimental therapeutics will either live or die due to the development of the pandemic, on the contrary, we believe that once we have established the therapeutic benefits of this drug in the context of Covid-19, hopefully we should have our long-term vision for this drug too a kind of workhorse for emergency rooms and intensive care units as well as hospitals and hospital systems everywhere. “

Categories
Health

Recipes for Chocolate Truffles – The New York Occasions

Recipes for Chocolate Truffles - The New York Times

Slightly uneven little balls dusted with cocoa to simulate the bottom of a freshly dug mushroom – the black tuber melanosporum – define a chocolate truffle in its most basic form. Inside there is a firm but velvety center, a confection called ganache. Truffles are never cheap, but before taking the credit card out, consider the homemade variety. They couldn’t be easier to manufacture and don’t require special equipment. Under supervision, an 8-year-old can sculpt and dive truffles for a nice afternoon activity.

In addition to the classic version with a cocoa coating, chocolate truffles are often wrapped in a chocolate shell, which is sometimes decorated with nuts, frosting, and even gold leaf. Their taste can also be varied depending on whether you go for dark, milky, or white chocolate, adding ingredients like raspberry puree, nuts and coffee, or spirits like port, brandy and even champagne. Size also plays a role. Chocolate truffles should be just one bite and no more than an inch in diameter – three-quarters of an inch is ideal.

Time: 4 hours including chilling

Yield: approx. 40

6 ounces high quality semi-sweet or bittersweet chocolate, 70 percent cocoa

½ cup of heavy cream

3 tablespoons of ruby ​​port or grape juice

½ cup of unsweetened cocoa using the Dutch method

1. Cut the chocolate into small pieces, place in a small, heavy saucepan and add the cream. Place on low heat, stirring occasionally, until the chocolate has melted. Remove from heat, stir in port wine or juice; put in a bowl. Cover and refrigerate until mixture is firm, about 2 hours.

2. Spread a sheet of waxed paper or parchment paper on a baking sheet. Have a bowl of ice water ready. Use a spoon or spoon or melon baller to scoop up mounds of mixture about 3/4 inch in diameter. Roll lightly between the palms of your hands to form beautiful balls and place them on the paper. Occasionally moisten the spoon and your hands with ice water to keep the chocolate from sticking. Chill until firm, about 2 hours or overnight.

3. Spread the cocoa on a chilled plate. Take the truffles out of the refrigerator, roll them each in cocoa and place them back on the baking sheet. Cool to firm. Truffles can be frozen for up to a week.

Time: 6 hours including chilling

Yield: approx. 40

6 ounces high quality semi-sweet or bittersweet chocolate, 70 percent cocoa

½ cup of heavy cream

3 tablespoons of prosecco

½ pound high quality white chocolate to coat

1. Break the dark chocolate into small pieces, transfer them to a small, heavy saucepan and add the cream. Place on low heat, stirring occasionally, until the chocolate has melted. Remove from heat, stir in the prosecco and place in a bowl. Cover and refrigerate until mixture is firm, about 2 hours.

2. Spread a sheet of waxed paper or parchment paper on a baking sheet. Have a bowl of ice water ready. Use a spoon or spoon, or a melon baller, to scoop up mounds about 3/4 of an inch in diameter. Roll lightly between your palms to make beautiful balls and put them on paper. Occasionally moisten the spoon and your hands with ice water to keep the chocolate from sticking. Chill until firm, about 2 hours or overnight.

3. Break white chocolate into pieces and melt on top of a double boiler or place in a microwave-safe bowl and microwave at 50 percent power for 1 minute, stirring every 15 seconds. Let the chocolate cool to about 90 degrees at room temperature and stir it from time to time. Drop chilled truffles one at a time into melted chocolate and quickly lift them out with a small fork or professional wire dip loop to allow excess water to drain off. Place on a baking sheet and store in the refrigerator for about 2 hours.

Categories
Business

Disney to Reveal Plans to Turbocharge Streaming Choices

Disney to Reveal Plans to Turbocharge Streaming Offerings

LOS ANGELES – A major expansion of the Star Wars universe. Tom Hanks as Geppetto in a live action “Pinocchio” and Yara Shahidi as Tinker Bell in a live action “Peter Pan & Wendy”. Recordings of new Marvel projects. A star-studded prequel to “The Lion King”.

On Thursday, the Walt Disney Company will discuss a lot of upcoming Death Star-sized content in a four-hour investor presentation focused on streaming – all that and more, said three people with knowledge of the matter, who spoke on condition of anonymity Discussion of private planning.

Some big budget Disney films will continue to show exclusively in theaters. (The “Lion King” project directed by Barry Jenkins, which focuses on Mufasa’s backstory, is a great choice.) Others will debut online. (This is where Pinocchio comes in.) All of them will ultimately serve one goal, namely to empower Disney +, the company’s flagship streaming service.

At a time when streaming is becoming increasingly competitive – and some of Disney’s traditional companies are struggling – Disney hopes to use the virtual event to dazzle Wall Street: here is a 97-year-old company making the leap in creates the hyperspace from direct customers to consumers.

Last month, Bob Chapek, Disney’s CEO, announced that Disney + had reached 74 million subscribers worldwide after just 11 months of operation. (It took Netflix seven years to reach that threshold and now has 195 million customers worldwide.) Since then, Disney + has been launched in Latin America and grown rapidly in India, analysts say. Some estimate that Disney may reveal that the service is within reach of 100 million subscribers.

Disney is also expected to release growth updates to its other streaming platforms, including ESPN +, Hulu, and a new general entertainment offering, Star, which will be rolled out overseas in the coming months.

“The question everyone has now is where to go from here?” Michael Nathanson, founder of media research firm MoffettNathanson, said in a telephone interview. “We expect much more spending on content to make Disney + an always available service that increases pricing power.”

Subscriptions to Disney + are $ 7 per month. The cheapest Netflix plan is $ 9 a month, and HBO Max, a young WarnerMedia service, is $ 15.

Disney declined to comment on this article.

Investors have kissed their lips in anticipation of what Disney will reveal, including projections of subscriber growth. Disney stock is up 32 percent since Investor Day announced in August, compared with Standard & Poor’s 500-stock index, up 11 percent.

Disney was trading at around $ 155 on Wednesday, near an all-time high, although some of its theme park resorts (which are huge money generators) remain closed because of the pandemic. The company laid off 30,000 employees.

Hollywood is keen on the investor presentation as Disney executives have announced that they will be discussing an evolving approach to film distribution. The coronavirus has forced Disney and other studios to postpone the release of more than a dozen major films and redirect others to streaming services. In September, Disney debuted “Mulan” on Disney + as part of a “Premium Access” experiment and billed subscribers $ 30 for perpetual access. Pixar’s latest film, Soul, will be released on Disney + on Christmas Day at no additional cost.

Citing the pandemic, WarnerMedia switched 17 upcoming Warner Bros. films to a hybrid release model last week – arriving on HBO Max and in theaters simultaneously – although some of the films (“Dune”, “The Matrix 4”) not scheduled to come out until the fourth quarter, long after vaccines are expected to be used. The surprise move resulted in a quick and severe setback for the WarnerMedia talent, who felt betrayed by the sudden change. You also get significantly lower paydays.

John Stankey, the executive director of AT&T, which owns Warner Media, described the excitement at a conference Tuesday as “a lot of noise” and predicted that WarnerMedia’s strategy would prove to be “win-win-win”.

Economy & Economy

Updated

Apr. 11, 2020, 6:16 pm ET

In contrast, Disney’s CEO Chapek and Robert A. Iger will not be taking a single approach to movie releases in 2021, according to people who know the company’s plan.

Some titles on Disney’s cinema board will be moved to Disney + at no additional cost. Expect “Peter Pan & Wendy” like “Soul” and “Pinocchio” to debut this way.

Other films will take the “Mulan” route and arrive on Disney + as premium offers. “We have something here in terms of leading access strategy,” Chapek told analysts on a recent conference call. “With our portfolio of services there will be a strategic role.”

And some of Disney’s greatest films will continue to receive exclusive theatrical releases before being added to the company’s streaming services. For example, contrary to popular speculation, Black Widow, a highly anticipated Marvel spectacle, will stay on Disney’s theatrical calendar for May 7th, people with knowledge of the presentation said.

Movies are helpful in attracting subscribers, but TV shows stream customers who pay month after month. To this end, Disney has an abundance of series for its services along the way. These include “Turner and Hooch,” an adaptation of the 1989 film about a detective and his oversized mutt; “Willow”, an adaptation of the large-screen fantasy from 1988; and eight Marvel shows based on characters like Loki and She-Hulk.

Streaming is not yet profitable for Disney – far from it. Direct sales losses were $ 2.8 billion in fiscal 2020. Streaming-related losses are expected to peak in 2022 as rollout costs decrease and content costs normalize. Analysts expect Disney + to be profitable by 2024.

Disney has stated that some of the money for its new content flash will come from programming budgets for its traditional television networks. The company owns the Disney Channel, National Geographic, FX, Freeform and ABC, among others.

“We will be shifting the scale from linear networks to our direct customer business,” said Chapek on the recent conference call.

Analysts pushed for additional details. “Just wait until December 10th,” said Christine McCarthy, Disney’s chief financial officer, on the call. “Hopefully then we can answer all of your questions.”

Categories
Entertainment

FKA twigs Sues Shia LaBeouf, Citing Abusive Relationship

FKA twigs Sues Shia LaBeouf, Citing Abusive Relationship

But living with him was getting scary, she said. The lawsuit says that he kept a loaded gun by the bed and that she was afraid to go to the bathroom at night so he wouldn’t mistake her for an intruder and shoot her. He didn’t let her wear clothes to bed and led a minor disagreement – over an artist she liked, and he didn’t, for example – to a nightly fight that had deprived her of sleep, the suit says.

The situation came just as she was finishing her most acclaimed album “Magdalene”. Ms. Barnett said she was stasis, having difficulty performing her job duties, and confusing her friends and colleagues. “Twigs is always the driving force behind their careers – always one step ahead,” said their long-time manager Michael Stirton. “This was an extreme change in her personality and character.” The album’s release was delayed several times and a tour was postponed at a high cost, Mr Stirton said when Mrs Barnett resigned. “I could talk to her,” he said. “But I couldn’t reach her.”

As Ms. Barnett became more isolated, she said she felt that her safety nets were about to fall apart. The gas station incident happened in public, she said, and no one came to her aid. An early attempt to tell a colleague was abandoned. “I just thought to myself that nobody will ever believe me,” she said in an interview. “I’m unconventional. And I am a colored person who is female. “

With the help of a therapist, she slowly began to strategize her exit. While she was packing to leave in the spring of 2019, Mr LaBeouf showed up unannounced and terrorizing her in the lawsuit, according to an affidavit from a witness, her housekeeper. When Ms. Barnett refused to go with him, the statement said he “forcibly grabbed” her, picked her up, and locked her in another room where he yelled at her.

Escaping him appeared “both difficult and dangerous,” the lawsuit said. And even when she got determined, she felt overwhelmed, she told her therapist in an email checked by The Times. Despite having the funds, it took Mrs Barnett several attempts to break free, she said in an interview. And only then did she realize how broken she had become.

“The whole time I was with him I could have bought a business ticket back to my four-story townhouse in Hackney,” she said in London. And yet she didn’t. “He got me so deep that the idea of ​​leaving him and coming back to work just seemed impossible,” she said.

Categories
Business

Ought to Corporations Require Staff to Get Vaccinated?

F.D.A. Clears Pfizer Vaccine, and Millions of Doses Will Be Shipped Right Away

In 1905, the Supreme Court ruled against a pastor, Henning Jacobson, who sued the state of Massachusetts for asking residents to take a vaccine after an outbreak of smallpox. “Genuine freedom for all could not exist under the application of a principle that recognizes the right of each and every person to use his or her own, be it in relation to himself or his property, regardless of the harm that may be done to others. ” Court ruled. “So it is the legally regulated freedom.”

This and other decisions have repeatedly reaffirmed this principle. Private companies can choose to hire, fire, or do business with employees unless they discriminate on the basis of a protected category.

There is still room for interpretation. Lawyers could argue that in previous cases, an emergency-only drug approved by the FDA was not considered, as will be the case with the early coronavirus vaccines. Or maybe a more conservative Supreme Court would be open to reiterating previous precedents.

The road to a coronavirus vaccine ›

Answers to your vaccine questions

With a coronavirus vaccine spreading out of the US, here are answers to some questions you may be wondering about:

    • If I live in the US, when can I get the vaccine? While the exact order of vaccine recipients may vary from state to state, most doctors and residents of long-term care facilities will come first. If you want to understand how this decision is made, this article will help.
    • When can I get back to normal life after the vaccination? Life will only get back to normal once society as a whole receives adequate protection against the coronavirus. Once countries have approved a vaccine, they can only vaccinate a few percent of their citizens in the first few months. The unvaccinated majority remain susceptible to infection. A growing number of coronavirus vaccines show robust protection against disease. However, it is also possible that people spread the virus without knowing they are infected because they have mild symptoms or no symptoms at all. Scientists don’t yet know whether the vaccines will also block the transmission of the coronavirus. Even vaccinated people have to wear masks for the time being, avoid the crowds indoors and so on. Once enough people are vaccinated, it becomes very difficult for the coronavirus to find people at risk to become infected. Depending on how quickly we as a society achieve this goal, life could approach a normal state in autumn 2021.
    • Do I still have to wear a mask after the vaccination? Yeah, but not forever. The two vaccines that may be approved this month clearly protect people from contracting Covid-19. However, the clinical trials that produced these results were not designed to determine whether vaccinated people could still spread the coronavirus without developing symptoms. That remains a possibility. We know that people who are naturally infected with the coronavirus can spread it without experiencing a cough or other symptoms. Researchers will study this question intensively when the vaccines are introduced. In the meantime, self-vaccinated people need to think of themselves as potential spreaders.
    • Will it hurt What are the side effects? The vaccine against Pfizer and BioNTech, like other typical vaccines, is delivered as a shot in the arm. The injection is no different from the ones you received before. Tens of thousands of people have already received the vaccines, and none of them have reported serious health problems. However, some of them have experienced short-lived symptoms, including pain and flu-like symptoms that usually last a day. It is possible that people will have to plan to take a day off or go to school after the second shot. While these experiences are not pleasant, they are a good sign: they are the result of your own immune system’s encounter with the vaccine and a strong response that ensures lasting immunity.
    • Will mRNA vaccines change my genes? No. Moderna and Pfizer vaccines use a genetic molecule to boost the immune system. This molecule, known as mRNA, is eventually destroyed by the body. The mRNA is packaged in an oily bubble that can fuse with a cell, allowing the molecule to slide inside. The cell uses the mRNA to make proteins from the coronavirus that can stimulate the immune system. At any given moment, each of our cells can contain hundreds of thousands of mRNA molecules that they produce to make their own proteins. As soon as these proteins are made, our cells use special enzymes to break down the mRNA. The mRNA molecules that our cells make can only survive a few minutes. The mRNA in vaccines is engineered to withstand the cell’s enzymes a little longer, so the cells can make extra viral proteins and trigger a stronger immune response. However, the mRNA can hold for a few days at most before it is destroyed.

For the past week, I’ve spoken to executives at companies in various industries to find out if they require vaccination of employees or customers. Nobody wanted to speak in the file.

Almost everyone said they wanted to recommend the vaccine but not make it mandatory. Some said they tried to create a culture of trust and a vaccine mandate would undermine that trust. Others were concerned about legal liability if an employee experienced adverse side effects from the vaccine. Some said they would like to commission the vaccine, but feared a backlash could turn into a public relations nightmare.

This is not a hypothetical thought experiment. When the executive director of Qantas, the Australian airline, said he would require passengers to be vaccinated – “certainly for international visitors and people leaving the country, we consider it a necessity,” he said – the backlash was quick. A travel agent in the UK stopped booking flights with the airline, stating: “We believe that physical autonomy in relation to medical interventions is a personal choice and should not be imposed by companies on people.”

It’s understandable that leaders would be afraid to promote potential controversy, but leadership is about making tough decisions when the stakes are high. Just recommending the vaccine may not be enough.

Categories
Health

Covid Affected person Examine Reveals Some Profit From an Arthritis Drug

Covid Patient Study Shows Some Benefit From an Arthritis Drug

Adding an arthritis drug called baricitinib to Covid treatment regimens that contains the antiviral drug remdesivir can cut recovery times by a day or more, especially for those who are seriously ill, according to a study published Friday.

The results of a government-sponsored clinical trial were released more than three weeks after the Food and Drug Administration received an emergency approval for double treatment. Earlier this month, some experts said they were uncomfortable using medication without a chance to review the underlying data backing their performance. Last month, the World Health Organization also recommended rejecting remdesivir for treating Covid patients as there was no evidence of its use.

In previous press releases, limited results were disclosed showing that hospitalized Covid patients treated with baricitinib and remdesivir recovered one day faster than those who received remdesivir alone.

Some questioned the adoption of the combination treatment because baricitinib came at a high price – which could be around $ 1,500 per patient – and also cited side effects like blood clots. Several doctors also wondered if adding baricitinib would be worth it, since steroids like dexamethasone were cheap and widely available. Both baricitinib and dexamethasone are believed to suppress the excessive inflammation that causes many severe cases of Covid.

The new paper, published in the New England Journal of Medicine, adds some granularity to the results and shows that certain subsets of patients benefited far more from the addition of baricitinib than others. The study included more than 1,000 hospital patients with Covid, all of whom received remdesivir. People who were sick enough to need high doses of supplemental oxygen or non-invasive ventilation recovered eight days faster when baricitinib was included in their medication.

In these groups, “I think the data clearly support a role for baricitinib,” said Dr. Boghuma Kabisen Titanji, an infectious disease doctor at Emory University who pioneered early studies of baricitinib against the coronavirus.

Dr. Titanji also noted that the data suggested that certain patients may be less likely to die or need a ventilator when taking baricitinib in addition to remdesivir. However, like those showing faster recovery times, these results were inconsistent among study participants.

Dr. Lauren Henderson, a pediatric rheumatologist at Boston Children’s Hospital, said she was encouraged by the results and the prospect of another option in the coronavirus treatment arsenal.

She and several other experts added that they may still have a tendency to use dexamethasone as a treatment for seriously ill Covid-19 patients who needed respiratory support.

In contrast to baricitinib, studies have shown that dexamethasone inhibits mortality in seriously ill Covid patients. It’s also inexpensive and easy to get hold of, while baricitinib is more of a specialty drug and may pose barriers to the supply chain, said Dr. Erin McCreary, Infectious Disease Pharmacist at the University of Pittsburgh.

New treatments for Covid-19

Things to know about Covid-19 treatment

Confused By The Terms To Treat Covid-19? Let us help:

    • ACE-2: A protein that sits on the surface of certain types of human cells. The coronavirus has to bind to ACE-2 in order to enter cells.
    • Adverse event: A health problem that occurs in volunteers in a clinical trial with a vaccine or drug. An adverse event is not always caused by the treatment tested in the study.
    • Antibody: A protein produced by the immune system that can attach to a pathogen such as the coronavirus and prevent it from infecting cells.
    • Antiviral drug: A drug that affects the ability of a virus to replicate in cells. The first drug approved in the United States for Covid-19, Remdesivir, is antiviral.
    • Approval, Licensing, and Approval for Emergency Use: Medicines, vaccines and medical devices cannot be sold in the US for no profit approval by the Food and Drug Administration, also known as Licensing. After a company submits the results of clinical studies to the FDA for review, the agency decides whether the product is safe and effective. This process usually takes many months. If the country faces an emergency – like a pandemic – a company can file an application instead Emergency approvalthat can be granted much faster.
    • Compassionate Use: A term used to describe treatments given to seriously ill people even though they have not yet been approved for that use by the Food and Drug Administration.
    • Cytokine storm: An overactive immune system reaction that can lead to massive inflammation and tissue damage. Cytokine storms can be responsible for many of the severe cases of Covid-19, and a number of researchers are testing drugs that may calm them down.
    • Interferon: A molecule of the immune system. Certain types of interferons can cause inflammation in the body while others can contain it. Still other types can stimulate cells to strengthen their defenses against viruses. Researchers are investigating whether treating synthetic interferons can help people fight off the coronavirus.
    • Monoclonal Antibodies: Monoclonal antibodies made in a laboratory mimic the natural antibodies made by the immune system. A number of companies have developed these treatments for Covid-19. President Trump received Regeneron’s antibody treatment soon after the disease was diagnosed.
    • Phases 1, 2 and 3 studies: Clinical trials typically take place in three phases. Phase 1 studies typically involve a few dozen people to determine whether a vaccine or drug is safe. In Phase 2 trials that involve hundreds of people, researchers can try different doses and take more measurements of the vaccine’s effects on the immune system. Phase 3 trials, involving thousands or tens of thousands of volunteers, determine the safety and effectiveness of the vaccine or medicine by waiting to see how many people are protected from the disease it is intended to be used against.
    • Placebo: A substance with no therapeutic effect that is widely used in clinical trials. For example, to see if a vaccine can prevent Covid-19, researchers can inject the vaccine into half of their volunteers while the other half are given a placebo with salt water. You can then compare how many people are infected in each group.
    • Post-market surveillance: The surveillance that occurs after a vaccine or drug has been approved and regularly prescribed by doctors. This typically confirms that the treatment is safe. Rarely, side effects are noted in certain groups of people that were overlooked during clinical trials.
    • Preclinical Research: Studies that take place prior to the start of a clinical trial typically include experiments that test a treatment on cells or animals.
    • Test protocol: A series of procedures that must be performed during a clinical trial.
    • Retrospective study: A study that analyzes data collected in the past to determine how effective a treatment is. Retrospective studies can provide useful information, but they are not as definitive as randomized clinical studies.
    • Spike protein: A protein that sits on the surface of coronaviruses. The spike protein binds to the ACE-2 receptor on human cells using a region called the receptor binding domain (RBD). As soon as the protein accumulates, the virus can enter the cell. Many vaccines and monoclonal antibody treatments are designed to stick to the tip.
    • Standard of care: A treatment that is accepted by medical experts as an appropriate method to treat a specific type of disease. Once a standard for treating a disease is established, new experimental treatments are usually tested against it rather than a placebo.

Several experts pointed to another study by the National Institutes of Health that seeks to directly compare two combination treatment regimens: one in which hospital patients receive remdesivir and baricitinib, and one in which remdesivir is paired with dexamethasone. Dr. McCreary also noted the importance of studying patients receiving both baricitinib and dexamethasone “to see if there is any incremental benefit.”

Dr. Andre Kalil, an infectious disease doctor at the University of Nebraska Medical Center and lead researcher on the new paper, noted that while dexamethasone had already become a widely accepted treatment for Covid-19, the steroid still needed further study. He cited “a variety of serious safety issues” with the drug that warranted thorough investigation.

Like other steroids, dexamethasone, which largely reduces inflammation, can be associated with a variety of undesirable side effects, including worsening conditions like diabetes or osteoporosis.

Categories
Politics

Man Is Arrested in Stabbing at D.C. Election Protest

Man Is Arrested in Stabbing at D.C. Election Protest

Washington, DC authorities said Sunday they had arrested a man in connection with the stabbing of four people on Saturday night when supporters and opponents of President Trump collided with blocks from the White House.

The four were stabbed to death outside a bar on 11th Street and F Street Northwest at around 9 p.m. Saturday, the Metropolitan Police Department said in a statement. Washington, 29-year-old Phillip Johnson was arrested and charged with assault with a dangerous weapon, a police spokeswoman said. According to a police report, he used a knife.

The confrontation was one of several furious encounters in Washington and state capitals on Saturday as supporters of Mr. Trump were outraged by a Supreme Court ruling that further demolished the president’s hopes of dismissing the November election results Counter-protesters clashed.

These confrontations escalated to violence in a number of locations, including Olympia, Washington, where police rioted and one person was shot.

The Washington police incident report on the stabbing in Washington said that officials working on the demonstrations responded to reports of a fight outside Harry’s bar on F Street Northwest, in which they found four people with stab wounds. The Washington Post reported that the bar was used on Saturday as a meeting place for the Proud Boys, a right-wing group known for inciting violence during protests.

The confrontation came after dozen of Mr. Trump’s supporters, many of whom appeared to be members of the Proud Boys, gathered on the street outside Harry’s bar. Some of the Trump supporters shouted and pointed at a black man in dark clothing, standing alone and against a wall, according to a journalist who witnessed the confrontation while covering the protests for the New York Times.

At least three of Trump’s supporters offered to let the man go and pleaded with the others to let him go in peace. After about a minute, when the man hesitated, more protesters came closer and started punching and kicking him, according to video footage of the confrontation shared by the New York Post.

At this point, the man pulled out a knife and started cutting it up as more protesters piled on top of him. The man detached himself twice, but was then grabbed and beaten again. Police intervened after the man was lying face down on the floor. Several protesters shouted that the man had a knife and had stabbed someone. The man’s face was puffy and bloody when the police picked him up.

The victims were conscious and breathing when they were rushed to a hospital, a police department spokeswoman said on Sunday. Douglas Buchanan, a spokesman for DC Fire and Ambulance Services, said Sunday that her injuries were not life threatening.

Police identified the men who had been stabbed to be Franklin Todd Gregory of McMinnville, Tenn .; Corey Owen Nielsen of Robbinsdale, Minn .; Jeremy Bertino of Locust, NC; and Gregory Lyons, whose hometown was not released. Police said Mr. Gregory identified Mr. Johnson as the man who stabbed him.

Mr Johnson could not be reached on Sunday. It wasn’t immediately clear whether he was still in custody or whether he had a lawyer.

Minutes before the knife wounds, Mr. Trump supporters tore off a banner from Black Lives Matter and burned it in the street. Videos on social media show this. The flag was removed from outside the Asbury United Methodist Church, one of the oldest black churches in Washington, which has stood on the corner of 11th Street and K Street Northwest since 1836.

The Church’s senior pastor, Rev. Dr. Ianther M. Mills, in a statement, said the scene reminded him of a burning cross.

“We are a resilient people who have trusted in God through slavery and the subway, Jim Crow and the civil rights movement,” she said, “now that we are facing an obvious rise in white supremacy.”

Another video showed a sign with the slogan Black Lives Matter torn down by the Metropolitan African Methodist Episcopal Church near the corner of 15th Street and M Street Northwest. A police department spokeswoman said the authorities are aware of the incidents and are investigating them as possible hate crimes.

“DC’s faith-based organizations are at the heart of our community and give us hope in the face of darkness,” Washington Mayor Muriel Bowser said in a statement on Facebook. “They embody our DC values ​​of love and inclusivity. An attack on them is an attack on all of us. “

The police department spokeswoman said eight officers were injured during the protests on Sunday. Two of these officers suffered serious, but not life-threatening injuries and were also taken to hospitals, said Buchanan, the fire and rescue service spokesman.

According to a police arrest database, a total of 33 people were arrested in connection with the protests in Washington from Saturday afternoon to Sunday morning, mainly for various types of assault, including attacks on police officers.

A single shot can be heard in videos of a clash in Olympia, Washington posted on social media as counter-protesters advance against members of a pro-Trump group on Saturday, including a person on a sidewalk saying a great Trump waving flag. After the shot, one of the counter-protesters falls to the ground while others call for help. Another video shows a man with a gun running from the scene and putting on a red hat.

Forest Michael Machala, 25, of Shoreline, Washington, was arrested for first degree assault, said Chris Loftis, a Washington State Patrol spokesman, on Sunday.

The Olympia shots came after Mr. Trump’s supporters and counter-protesters gathered near the state capitol on Saturday afternoon and clashed ahead of the shooting.

Olympia Police said there were four arrests and four officers were injured, according to CBS subsidiary KIRO.

Victor J. Blue, Mike Baker and Nicholas Bogel-Burroughs contributed to the coverage.

Categories
Business

Wall Road Journal Opinion Editor Defends Merchandise on Dr. Jill Biden

Wall Street Journal Opinion Editor Defends Item on Dr. Jill Biden

The editor of the editorial page of the Wall Street Journal accused strategists of President-elect Joseph R. Biden Jr. of initiating a coordinated response to an article published Friday night urging Jill Biden, wife of Mr. Biden, not to refer to himself as “Dr. Biden ”because she is not a doctor, but is doing a doctorate in education.

After two master’s degrees, Dr. Biden from the University of Delaware in 2007. She also taught English at a community college in Virginia, and hopes to continue to do so while serving as first lady.

“The Ph.D. may once have held prestige, but that has been diminished by the erosion of seriousness and the loosening of standards in university education in general, ”Joseph Epstein wrote in the comment.

In the response, published on Sunday evening and for the Monday newspaper, Paul A. Gigot, the top editor of the journal’s opinion division for nearly two decades, pointed out negative comments on Mr. Epstein’s article, that of two Biden employees as well Douglas Emhoff, the husband of Senator Kamala Harris, the elected vice president, was posted on Twitter as evidence of a campaign.

“Why go so far as to highlight a single comment on a relatively small subject?” wrote Mr Gigot, who elsewhere said the replies reflected “which was clearly a political strategy”. “I suspect the Biden team concluded that it was a chance to use the great weapon of identity politics to send a message to critics as they prepare to take power. There’s nothing like playing race or the gender card to stifle criticism. “

Mr. Gigot said the press generally supported the negative interpretation of the article (he referred to an article in the New York Times about it). And he defended the play.

“Ms. Biden is America’s most prominent graduate student today and has a leadership role in educational policy,” wrote Gigot. “She cannot be closed to comment.”

He also noted that Mr. Epstein’s argument that PhD students were not the “Dr.” Biden is out of place because Mr Biden also used the term in relation to his wife. He compared the tweets from Biden employees to those in which President Trump described the press as an “enemy of the people”.

A Wall Street Journal spokeswoman declined to comment. A Biden spokeswoman did not comment immediately.

The conservatism of the journal’s opinion side – which preceded Rupert Murdoch’s purchase of the Journal’s parent company, Dow Jones & Company, in 2007 for $ 5 billion – has occasionally caused friction with the Journal’s newsroom, which like most newspapers, does not is officially political.

Mr. Epstein’s play is likely to create further tension. For example, a college reporter for The Journal said on Twitter over the weekend that such opinion pieces “make it harder for me to do my job”.

As with other newspapers, including The Times and The Washington Post, the journal’s news sections and opinion pages are maintained separately, each monitored by a top editor who reports to the newspaper’s editor.

At least three times this year members of the journal’s newsroom have sent letters criticizing the journal’s columns.

In July, nearly 300 news workers sent a letter to the journal’s editor, Almar Latour, stating a “lack of fact-checking and transparency” on the opinion counter. The letter referred to several articles, including Vice President Mike Pence’s June 16 essay entitled “There is no coronavirus, second wave”. In response, the journal published an unsigned editorial complaining about the “progressive abandonment culture”. it was said that the letter was typical.

In June, the union’s board of directors, which represents the Journal’s staff, sent a letter to Mr Latour and Matt Murray – the Journal’s editor-in-chief who oversaw the news section – asking Gerard A. Baker, the former editor-in-chief and now an editor in general , be placed in the opinion area and criticize an article by him and several of his Twitter posts. He was reassigned the day after the letter was posted, despite a spokeswoman for the Journal saying a move was in the works.

In February, the headline of an article by columnist Walter Russell Mead criticizing China’s response to the coronavirus prompted more than 50 news workers, many of whom were based in China, to sign a letter to the Dow Jones chief executive and Mr. Murdoch’s chief executive News Corp. asks to withdraw. The headline calling China the “Real Sick Man of Asia” was “derogatory,” the letter reads. The headline was not withdrawn and the Chinese government soon expelled three journal reporters in what it termed retaliation.

In response on Sunday, Mr. Gigot promised not to be impressed by the reaction to the article. “If you disagree with Mr. Epstein, fair enough. Write a letter or shout your objections on Twitter, ”he wrote. “But these sites won’t stop posting provocative essays just because they insult the new government or political censorship in the media and academia.”